SDC1 and Miyoshi myopathy: Our data further support current IMS/IMWG consensus, which has updated MM prognostic classification and recommends that TP53mut, identified using NGS-based methods on CD138-positive/purified cells, should be included in the HR MM definition (Avet-Loiseau et al. 2025).